$1.960
-0.030 (-1.51%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
PACB 相似圖表分析預測
Alphio's PACB stock price prediction model matches the current Pacific Biosciences of California Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.98 (+0.98%). The 1-week path is $2.04 (+3.86%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Pacific Biosciences of California Inc 股票嗎？
Given the current price of $2.33, the stock is not a strong buy at this moment. The RSI is at 52.275, indicating a neutral momentum, and the forward P/E is at 0, suggesting uncertainty in future earnings. The recent revenue guidance cut to $155 million to $165 million raises concerns about financial stability. However, the stock has shown a significant 79.23% increase over the last 20 days, indicating potential for recovery. The main risk is the net income loss of $44.7 million reported in Q2 2026, which could impact investor confidence.
PACB 股價於 Thursday 收在 $1.96，此前下跌 -1.51%
Pacific Biosciences of California Inc (PACB) last closed at $1.96, losing -1.51%. These facts feed the 1-day and 1-week PACB price prediction above.
分析師一致預期
Pacific Biosciences of California Inc（PACB）：買進 2、持有 4、賣出 0。展望：Hold。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
預測驅動因素
Pacific Biosciences of California Inc（PACB）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
相似圖表形態
近期走勢與 PACB 最接近的股票，依相似度排序。
PACB 季節性分析
Historically the probability of a positive October return for PACB is 36.84%. January offers the highest probability of a positive month at 44.26%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
PACB 十年價格預測
| 月份 | 最低價 | 平均價 | 最高價 | 潛在報酬率 |
|---|---|---|---|---|
| Oct 2026 | $0.86 | $0.93 | $1.07 | -52.41% |
| Nov 2026 | $0.83 | $0.98 | $0.99 | -50.08% |
| Dec 2026 | $0.96 | $0.99 | $1.08 | -49.46% |
2026 年，Pacific Biosciences of California Inc（PACB）預計區間為 $0.83 至 $1.08。
Pacific Biosciences of California Inc 2026 年月度預測
2026 年 Oct，Pacific Biosciences of California Inc 預計均價 $0.93，最低 $0.86，最高 $1.07。
2026 年 Nov，Pacific Biosciences of California Inc 預計均價 $0.98，最低 $0.83，最高 $0.99。
2026 年 Dec，Pacific Biosciences of California Inc 預計均價 $0.99，最低 $0.96，最高 $1.08。
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。